Skyline Medical Inc. (SKLN) 0.1300 $SKLN
Skyline Medical Announces Private Placement of Senior Convertible Notes and Warrants
ACCESSWIRE - Thu Jul 24, 8:25AM CDT
MINNEAPOLIS, MN / ACCESSWIRE / July 24, 2014 / Skyline Medical Inc. (OTCQB: SKLN) (the "Company"
today announced the sale, in a private placement, of a senior convertible note, in the original principal amount of $610,978 (the "Investor Note", due on July 23, 2015, and a warrant (the "Investor Warrant" to initially acquire up to 2,036,593 shares of the Company's common stock (the "Investor Warrant Shares". The Investor Warrant is exercisable at an exercise price of $0.165 per share and expires on July 23, 2019. The purchase price for the Investor Note and Investor Warrant was $500,000.
Skyline Medical Announces Two New Trials of the STREAMWAY(R) System
Marketwire - Wed Jun 18, 9:45AM CDT
Skyline Medical Inc. (OTCQB: SKLN) today announced that two new trials of the STREAMWAY Fluid Waste Management System are underway in North Carolina and California. Brier Creek Ambulatory Surgery Center, affiliated with the Duke Health Care System, and located in Raleigh, North Carolina, is in the process of validating the STREAMWAY Fluid Management System for endoscopic procedures. Additionally, Beverly Hospital, affiliated with the Adventist Health System, and located in Montebello, California, is conducting a trial in its radiology department.
Skyline Medical Announces 24 New STREAMWAY® System Installations for Large National Ambulatory Surgery Network
PR Newswire - Wed May 28, 7:30AM CDT
Skyline Medical Inc. (OTCQB: SKLN) is continuing to install a total of 24 new direct-to-drain STREAMWAY Fluid Waste Management Systems across the U.S. for an existing Skyline client. The client is one of the largest ambulatory networks in the United States and the shipments are being installed across surgical facilities in Texas, Minnesota, Arizona, Utah and Wisconsin.
Skyline Announces First Quarter 2014 Results
PR Newswire - Thu May 15, 7:30AM CDT
Skyline Medical Inc. (OTCQB: SKLN), producer of the FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal, today reported its results for the first quarter ended March 31, 2014.
Skyline Medical Reports 2013 Full-Year Results
PR Newswire - Thu Mar 27, 7:00AM CDT
Skyline Medical Inc. (OTCQB: SKLN) -- producer of the FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal -- today reported its results for the full year ended December 31, 2013.
Multiple Insiders of Skyline Medical Inc. (SKLN)-Other O bought Shares of SKLN
M2 - Fri Mar 21, 7:39AM CDT
Reported by InsiderCow.com at 2014-03-20 10:36:27 ET
Skyline Medical to Demonstrate Revolutionary Technology at Association of periOperative Registered Nurses Conference
PR Newswire - Tue Mar 18, 7:30AM CDT
Skyline Medical (OTCQB: SKLN) will exhibit its revolutionary, FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal at the Association of periOperative Registered Nurses (AORN) Surgical Conference & Expo in late March in Chicago.
Skyline Medical to Penetrate Important Northeast Region Through Exclusive Distribution Agreement with O.R. Specialties
PR Newswire - Thu Mar 13, 7:30AM CDT
To expand the reach of its FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal in the influential northeast region of the United States, Skyline Medical (OTCQB: SKLN) recently signed a distribution agreement with O.R. Specialties.
Skyline Medical Expands Sales Force to Meet Growing Demand
PR Newswire - Mon Feb 24, 7:30AM CST
Skyline Medical (OTCQB: SKLN) has assembled a dynamic team of sales leaders to build out a larger U.S. sales force in response to increasing demand for its STREAMWAY System -- a revolutionary, FDA-approved system for automated, direct-to-drain medical fluid disposal.
Skyline Medical Announces $2.06 Million Private Placement Transaction
PR Newswire - Wed Feb 05, 7:30AM CST
Skyline Medical Inc. (OTCQB: SKLN) (the "Company", producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain surgical fluid disposal, today announced that it has entered into a definitive agreement with investors, including Skyline Medical CEO Josh Kornberg, to sell in a private placement an aggregate 20,550 shares of Series A Convertible Preferred stock and warrants. The transaction was conducted without an underwriter or placement agent and resulted in gross proceeds to the Company of $2.06 million, before deducting offering expenses. The warrants are exercisable at an exercise price of $0.325 per share, which represents a purchase price of 125% per initial conversion price, and expire 5 years from the closing date. The convertible preferred stock will pay a 6% dividend annually and is convertible at a conversion price of $0.26 per share, subject to adjustment in certain circumstances.
Skyline Medical Expands Early Access to Its Revolutionary Fluid Waste Management System Through Attainia Partnership
PR Newswire - Thu Jan 30, 7:00AM CST
Skyline Medical (OTCQB: SKLN) is making it easier for hospitals and surgery centers to include state-of-the-art waste management systems in new and renovated facilities. The company is making its revolutionary, FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal available through Attainia software -- the world's most widely used healthcare equipment planning and budgeting software.
Skyline Medical's STREAMWAY® System Provides New Option for Radiology
PR Newswire - Thu Jan 02, 7:30AM CST
Skyline Medical Inc. (OTCQB: SKLN) (the "Company", formerly BioDrain Medical, producer of the FDA-approved STREAMWAY System for automated, direct-to-drain surgical fluid disposal, formally introduced its flagship system to radiologists, radiology administrators and technologists at the Radiological Society of North America Scientific Assembly and Annual Meeting last month. The technology was well accepted.
Prospect Park Capital Corp. Announces New Director and Engagement of Sponsor
Marketwire - Tue Dec 17, 5:53PM CST
Prospect Park Capital Corp. ("Prospect Park" (TSX VENTURE: PPK.P), a capital pool company as defined under Policy 2.4 ("Policy 2.4" of the TSX Venture Exchange (the "Exchange", is pleased to announce that its board of directors has appointed Joshua Kornberg as an additional director.
PhyMed Launches Successful Relationship with TriStar Skyline Medical Center
PRWeb - Tue Dec 10, 9:12AM CST
PhyMed Healthcare Group has been awarded the contract to provide anesthesia and pain management services to Nashville-based TriStar Skyline Medical Center, a 213-bed acute care facility.
Skyline Medical Expands Presence in Florida, Installing Multiple STREAMWAY® System Units at Winter Park Memorial Hospital
PR Newswire - Wed Sep 11, 7:30AM CDT
Skyline Medical Inc. (OTCQB: SKLN) (the "Company", formerly BioDrain Medical, producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain surgical fluid disposal, today announced that Winter Park Memorial Hospital, based in Winter Park, Fla., has purchased three STREAMWAY System units for its new endoscopy wing, opening this Fall.
Skyline Medical Enters Virginia Market, STREAMWAY® System Selected to Replace Recalled Technology at Ambulatory Surgical Suite
PR Newswire - Mon Sep 09, 7:49AM CDT
Skyline Medical Inc. (OTCQB: SKLN) (the "Company", formerly BioDrain Medical, producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain surgical fluid disposal, today announced that Advanced Orthopaedics, a privately held orthopedic practice based in Richmond, Va., has purchased three STREAMWAY System units to be installed in multiple surgical suits. These new installations will replace the recalled surgical waste disposal technology that had been used previously.
Skyline Medical Announces Second Quarter 2013 Results
PR Newswire - Wed Aug 14, 8:00AM CDT
Skyline Medical (OTCQB: SKLN) (the "Company", formerly BioDrain Medical, the producer of the FDA approved STREAMWAY(TM) System for automated, direct-to-drain surgical fluid disposal that reduces the risk of exposure to hazardous waste, today reported its results for the second quarter ended June 30, 2013.
Skyline Medical Announces Private Placement of Senior Convertible Notes and Warrants
ACCESSWIRE - Thu Jul 24, 8:25AM CDT
MINNEAPOLIS, MN / ACCESSWIRE / July 24, 2014 / Skyline Medical Inc. (OTCQB: SKLN) (the "Company"
today announced the sale, in a private placement, of a senior convertible note, in the original principal amount of $610,978 (the "Investor Note", due on July 23, 2015, and a warrant (the "Investor Warrant" to initially acquire up to 2,036,593 shares of the Company's common stock (the "Investor Warrant Shares". The Investor Warrant is exercisable at an exercise price of $0.165 per share and expires on July 23, 2019. The purchase price for the Investor Note and Investor Warrant was $500,000. Skyline Medical Announces Two New Trials of the STREAMWAY(R) System
Marketwire - Wed Jun 18, 9:45AM CDT
Skyline Medical Inc. (OTCQB: SKLN) today announced that two new trials of the STREAMWAY Fluid Waste Management System are underway in North Carolina and California. Brier Creek Ambulatory Surgery Center, affiliated with the Duke Health Care System, and located in Raleigh, North Carolina, is in the process of validating the STREAMWAY Fluid Management System for endoscopic procedures. Additionally, Beverly Hospital, affiliated with the Adventist Health System, and located in Montebello, California, is conducting a trial in its radiology department.
Skyline Medical Announces 24 New STREAMWAY® System Installations for Large National Ambulatory Surgery Network
PR Newswire - Wed May 28, 7:30AM CDT
Skyline Medical Inc. (OTCQB: SKLN) is continuing to install a total of 24 new direct-to-drain STREAMWAY Fluid Waste Management Systems across the U.S. for an existing Skyline client. The client is one of the largest ambulatory networks in the United States and the shipments are being installed across surgical facilities in Texas, Minnesota, Arizona, Utah and Wisconsin.
Skyline Announces First Quarter 2014 Results
PR Newswire - Thu May 15, 7:30AM CDT
Skyline Medical Inc. (OTCQB: SKLN), producer of the FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal, today reported its results for the first quarter ended March 31, 2014.
Skyline Medical Reports 2013 Full-Year Results
PR Newswire - Thu Mar 27, 7:00AM CDT
Skyline Medical Inc. (OTCQB: SKLN) -- producer of the FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal -- today reported its results for the full year ended December 31, 2013.
Multiple Insiders of Skyline Medical Inc. (SKLN)-Other O bought Shares of SKLN
M2 - Fri Mar 21, 7:39AM CDT
Reported by InsiderCow.com at 2014-03-20 10:36:27 ET
Skyline Medical to Demonstrate Revolutionary Technology at Association of periOperative Registered Nurses Conference
PR Newswire - Tue Mar 18, 7:30AM CDT
Skyline Medical (OTCQB: SKLN) will exhibit its revolutionary, FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal at the Association of periOperative Registered Nurses (AORN) Surgical Conference & Expo in late March in Chicago.
Skyline Medical to Penetrate Important Northeast Region Through Exclusive Distribution Agreement with O.R. Specialties
PR Newswire - Thu Mar 13, 7:30AM CDT
To expand the reach of its FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal in the influential northeast region of the United States, Skyline Medical (OTCQB: SKLN) recently signed a distribution agreement with O.R. Specialties.
Skyline Medical Expands Sales Force to Meet Growing Demand
PR Newswire - Mon Feb 24, 7:30AM CST
Skyline Medical (OTCQB: SKLN) has assembled a dynamic team of sales leaders to build out a larger U.S. sales force in response to increasing demand for its STREAMWAY System -- a revolutionary, FDA-approved system for automated, direct-to-drain medical fluid disposal.
Skyline Medical Announces $2.06 Million Private Placement Transaction
PR Newswire - Wed Feb 05, 7:30AM CST
Skyline Medical Inc. (OTCQB: SKLN) (the "Company"
, producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain surgical fluid disposal, today announced that it has entered into a definitive agreement with investors, including Skyline Medical CEO Josh Kornberg, to sell in a private placement an aggregate 20,550 shares of Series A Convertible Preferred stock and warrants. The transaction was conducted without an underwriter or placement agent and resulted in gross proceeds to the Company of $2.06 million, before deducting offering expenses. The warrants are exercisable at an exercise price of $0.325 per share, which represents a purchase price of 125% per initial conversion price, and expire 5 years from the closing date. The convertible preferred stock will pay a 6% dividend annually and is convertible at a conversion price of $0.26 per share, subject to adjustment in certain circumstances. Skyline Medical Expands Early Access to Its Revolutionary Fluid Waste Management System Through Attainia Partnership
PR Newswire - Thu Jan 30, 7:00AM CST
Skyline Medical (OTCQB: SKLN) is making it easier for hospitals and surgery centers to include state-of-the-art waste management systems in new and renovated facilities. The company is making its revolutionary, FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal available through Attainia software -- the world's most widely used healthcare equipment planning and budgeting software.
Skyline Medical's STREAMWAY® System Provides New Option for Radiology
PR Newswire - Thu Jan 02, 7:30AM CST
Skyline Medical Inc. (OTCQB: SKLN) (the "Company"
, formerly BioDrain Medical, producer of the FDA-approved STREAMWAY System for automated, direct-to-drain surgical fluid disposal, formally introduced its flagship system to radiologists, radiology administrators and technologists at the Radiological Society of North America Scientific Assembly and Annual Meeting last month. The technology was well accepted. Prospect Park Capital Corp. Announces New Director and Engagement of Sponsor
Marketwire - Tue Dec 17, 5:53PM CST
Prospect Park Capital Corp. ("Prospect Park"
(TSX VENTURE: PPK.P), a capital pool company as defined under Policy 2.4 ("Policy 2.4" of the TSX Venture Exchange (the "Exchange", is pleased to announce that its board of directors has appointed Joshua Kornberg as an additional director. PhyMed Launches Successful Relationship with TriStar Skyline Medical Center
PRWeb - Tue Dec 10, 9:12AM CST
PhyMed Healthcare Group has been awarded the contract to provide anesthesia and pain management services to Nashville-based TriStar Skyline Medical Center, a 213-bed acute care facility.
Skyline Medical Expands Presence in Florida, Installing Multiple STREAMWAY® System Units at Winter Park Memorial Hospital
PR Newswire - Wed Sep 11, 7:30AM CDT
Skyline Medical Inc. (OTCQB: SKLN) (the "Company"
, formerly BioDrain Medical, producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain surgical fluid disposal, today announced that Winter Park Memorial Hospital, based in Winter Park, Fla., has purchased three STREAMWAY System units for its new endoscopy wing, opening this Fall. Skyline Medical Enters Virginia Market, STREAMWAY® System Selected to Replace Recalled Technology at Ambulatory Surgical Suite
PR Newswire - Mon Sep 09, 7:49AM CDT
Skyline Medical Inc. (OTCQB: SKLN) (the "Company"
, formerly BioDrain Medical, producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain surgical fluid disposal, today announced that Advanced Orthopaedics, a privately held orthopedic practice based in Richmond, Va., has purchased three STREAMWAY System units to be installed in multiple surgical suits. These new installations will replace the recalled surgical waste disposal technology that had been used previously. Skyline Medical Announces Second Quarter 2013 Results
PR Newswire - Wed Aug 14, 8:00AM CDT
Skyline Medical (OTCQB: SKLN) (the "Company"
, formerly BioDrain Medical, the producer of the FDA approved STREAMWAY(TM) System for automated, direct-to-drain surgical fluid disposal that reduces the risk of exposure to hazardous waste, today reported its results for the second quarter ended June 30, 2013. 
